EX-16.1 2 exhibit161.htm EXHIBIT 16.1 Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - Immunoclin Corporation - Exhibit 16.1

 

 

 July 7, 2014

 

Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, D.C. 20549

 

We have read the statements of ImmunoClin Corporation pertaining to our firm included under Item 4.01 of Form 8-K dated January 7, 2014, and agree with such statements as they pertain to our firm.

 

Sincerely,

 

 

 

/s/ Sadler, Gibb & Associates, LLC